TREVI THERAPEUTICS INC's ticker is TRVI and the CUSIP is 89532M101. A total of 17 filers reported holding TREVI THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $687,912 | -10.5% | 315,556 | -1.9% | 0.00% | – |
Q2 2023 | $768,521 | +547.2% | 321,557 | +401.0% | 0.00% | – |
Q1 2023 | $118,739 | +13.7% | 64,183 | +18.6% | 0.00% | – |
Q4 2022 | $104,442 | +71.2% | 54,115 | +35.5% | 0.00% | – |
Q3 2022 | $61,000 | -53.1% | 39,927 | -13.8% | 0.00% | – |
Q2 2022 | $130,000 | +420.0% | 46,298 | +305.6% | 0.00% | – |
Q1 2022 | $25,000 | +177.8% | 11,414 | 0.0% | 0.00% | – |
Q4 2021 | $9,000 | -43.8% | 11,414 | 0.0% | 0.00% | – |
Q3 2021 | $16,000 | -38.5% | 11,414 | 0.0% | 0.00% | – |
Q2 2021 | $26,000 | -16.1% | 11,414 | 0.0% | 0.00% | – |
Q1 2021 | $31,000 | +10.7% | 11,414 | 0.0% | 0.00% | – |
Q4 2020 | $28,000 | -39.1% | 11,414 | 0.0% | 0.00% | – |
Q3 2020 | $46,000 | -56.2% | 11,414 | -28.7% | 0.00% | – |
Q2 2020 | $105,000 | +94.4% | 16,002 | -2.9% | 0.00% | – |
Q1 2020 | $54,000 | -12.9% | 16,480 | 0.0% | 0.00% | – |
Q4 2019 | $62,000 | -16.2% | 16,480 | 0.0% | 0.00% | – |
Q3 2019 | $74,000 | -40.3% | 16,480 | 0.0% | 0.00% | – |
Q2 2019 | $124,000 | – | 16,480 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 1,263,408 | $2,843,000 | 0.32% |
NEA Management Company, LLC | 5,940,796 | $13,367,000 | 0.17% |
TPG Group Holdings (SBS) Advisors, Inc. | 4,824,883 | $10,856,000 | 0.08% |
WealthTrust Axiom LLC | 39,500 | $88,000 | 0.03% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 34,600 | $78,000 | 0.00% |
BlackRock Inc. | 44,180 | $99,000 | 0.00% |
LPL Financial LLC | 10,000 | $23,000 | 0.00% |
Alberta Investment Management Corp | 25,000 | $56,000 | 0.00% |
Tower Research Capital LLC (TRC) | 4,187 | $10,000 | 0.00% |
Renaissance Technologies | 92,600 | $208,000 | 0.00% |